# Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

> **NCT05604131** · PHASE2 · RECRUITING · sponsor: **Rohan Dharmakumar** · enrollment: 89 (estimated)

## Conditions studied

- Acute Myocardial Infarction Type 1

## Interventions

- **DRUG:** Deferiprone Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05604131
- **Lead sponsor:** Rohan Dharmakumar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-08
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 89 (ESTIMATED)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05604131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05604131, "Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05604131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*